Vermillion Q1 Revenues Increase Sharply | GenomeWeb

NEW YORK (GenomeWeb) – Vermillion reported after the close of the market on Monday a more-than-threefold increase in its first quarter revenues. 

For the three months ended March 31, the Austin, Texas-based bioanalytical solutions firm said that total revenues rose to $951,000 from $305,000 in the year-ago quarter. 

The firm notched $635,000 in product revenues, up from $191,000 in Q1 2014, and $316,000 in license revenues, up from $114,000 a year ago. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.